Trial Profile
A Multicenter Parallel-group Study for Effect of Dapagliflozin on Dietary Behavior of Patients with Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2018
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 14 Sep 2018 Status changed from active, no longer recruiting to completed.
- 26 Jun 2018 Results presented at the 78th Annual Scientific Sessions of the American Diabetes Association
- 08 Apr 2018 Status changed from recruiting to active, no longer recruiting.